Ozempic-like drug fails to treat Parkinson's disease in new study; here's what the scientists said
Semaglutide, the drug used in Ozempic, has been linked to lowering the risk of Alzheimer's disease in the past. So, it was ...
Inside Ozzy Osbourne’s ‘very rare’ Parkinson’s diagnosis years after symptoms started
Ozzy Osbourne has been battling a rare form of Parkinson's Disease known as Parkin 2. In 2020, he disclosed to his fans that ...
Mike Tyson forced to release statement after Jake Paul’s now-retracted claim he was suffering from Parkinson’s
BOXING legend Mike Tyson has denied he is suffering from Parkinson’s disease – after a now-retracted claim from Jake Paul.
Early-onset Parkinson’s disease: Woman diagnosed at 27 reveals the warning signs
She was happily married, pregnant with her first child and had recently completed her residency in family medicine. Soon ...
Red flags of Parkinson's disease as mum is diagnosed at just 28 years old
Nicole LaBolle initially dismissed her shaking as something fairly common before facing a Parkinson's diagnosis at 28 ...
Judo offered to help manage Parkinson's symptoms
Finding your Feet with Parkinson's has been designed to use the power of sport and judo to support people living with the ...
Science Daily3d
Parkinson's News
can detect changes in Parkinson's symptoms over ... Caffeine Affects Brain Dopamine Function in Patients With Parkinson's Disease May 28, 2024 — Regular high caffeine consumption affects ...
eLife2d
Parkinson’s disease-associated Pink1 loss disrupts vesicle trafficking in Ensheathing glia causing dopaminergic neuron synapse loss
The preliminary data presented in this manuscript seem valuable. The data are currently incomplete and there are numerous technical concerns, some of which may arise from insufficient description of ...
Too Old to Operate4d
In Parkinson’s Disease, Talk Therapy Addresses Unmet Psychological Needs
In a recent study, talk therapy in Parkinson’s disease led to significant improvement in patients' well-being, problems/symptoms, and functioning.
PreveCeutical to Develop Sol-Gel N2B Platform for Parkinson's Disease
PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces a program ...
AstraZeneca’s diabetes drug fails to slow Parkinson’s progression in UCL trial
Researchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...